, Decision_act (EU) 1996/615

In forcesince 29 May 1996

As point 2.4 of the new Community framework for State aid for research and development (6) states, 'Public financing of R& D activities by public non-profit-making higher-education or research establishments is normally not covered by Article 92 (1) of the EC Treaty`. It should be noted that the IFP is a non-profit-making research institute (its statutes state that it is a non-commercial body ('à caractère non commercial`)).

It can hardly be claimed that the IFP carries out activities which are contrary to its statutes. However, it could be argued that, by selling its research findings at market prices, the IFP is acting in a manner incompatible with its statutes.

It could also be argued that a non-profit making establishment could transfer its findings without charge since it is not supposed to make profits. Instead of this, the IFP sells its findings at the market price (although the concept has no meaning in this field since most similar institutes are subsidized and do not therefore have to cover their costs) because the proceeds from the charge are not sufficient to finance all its activities and it needs additional funds.

In view of the fact that, under the new Community framework for State aid for R& D, public financing of non-profit-making research establishments is not covered by Article 92 (1) of the EC Treaty, any aid elements may be detected when findings are transferred to companies. This point was dealt with in Part III.

V

In the light of the above considerations, it has to be noted that, even though the IFP does not always charge the real cost of research to customers, it makes no distinction between the companies to which it transfers the findings of research carried out on its own behalf or on a collaborative basis. It cannot therefore be argued that French companies are the chief beneficiaries of the IFP's work.

It also transpired that the IFP does not give direct or indirect aid to firms and that firms controlled by the ISIS holding company are not accorded more favourable treatment than other companies. The IFP also receives an acceptable return on its holdings with ISIS.